Chirality in drug development: from racemic mixtures to enantiopure substances

Chirality in drug development: from racemic mixtures to enantiopure substances

In this Ardena Insight, we explore advanced crystallization techniques that transform racemic mixtures into enantiopure substances. These approaches ensure higher purity and targeted efficacy, playing a key role in the development of safer, more effective drugs.

With extensive expertise in drug substance development and solid state research, Ardena provides tailored solutions to support your chiral drug development needs.